NO148921C - Analogifremgangsmaate til fremstilling av immunpotenserende peptidderivater. - Google Patents

Analogifremgangsmaate til fremstilling av immunpotenserende peptidderivater.

Info

Publication number
NO148921C
NO148921C NO782138A NO782138A NO148921C NO 148921 C NO148921 C NO 148921C NO 782138 A NO782138 A NO 782138A NO 782138 A NO782138 A NO 782138A NO 148921 C NO148921 C NO 148921C
Authority
NO
Norway
Prior art keywords
immunpotencepating
preparation
peptide derivatives
analogy procedure
analogy
Prior art date
Application number
NO782138A
Other languages
English (en)
Other versions
NO148921B (no
NO782138L (no
Inventor
Lajos Zoltan Tarcsay
Albert Hartmann
Bruno Kamber
Jaroslav Stanek
Gerhard Baschang
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO782138L publication Critical patent/NO782138L/no
Publication of NO148921B publication Critical patent/NO148921B/no
Publication of NO148921C publication Critical patent/NO148921C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO782138A 1977-06-20 1978-06-19 Analogifremgangsmaate til fremstilling av immunpotenserende peptidderivater. NO148921C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77584 1977-06-20

Publications (3)

Publication Number Publication Date
NO782138L NO782138L (no) 1978-12-21
NO148921B NO148921B (no) 1983-10-03
NO148921C true NO148921C (no) 1984-01-11

Family

ID=19728618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782138A NO148921C (no) 1977-06-20 1978-06-19 Analogifremgangsmaate til fremstilling av immunpotenserende peptidderivater.

Country Status (18)

Country Link
EP (1) EP0000330B1 (no)
JP (2) JPS549224A (no)
AT (1) AT364095B (no)
AU (1) AU525005B2 (no)
CA (1) CA1139305A (no)
DD (1) DD139257A5 (no)
DE (1) DE2860893D1 (no)
DK (1) DK275178A (no)
ES (3) ES470961A1 (no)
FI (1) FI781933A (no)
GR (1) GR71681B (no)
IE (1) IE46957B1 (no)
IL (1) IL54950A (no)
NO (1) NO148921C (no)
NZ (1) NZ187611A (no)
PL (3) PL207766A1 (no)
PT (1) PT68188A (no)
ZA (1) ZA783504B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
DK0548024T3 (da) * 1991-12-19 1997-01-27 Ciba Geigy Ag Aminosulfonsyrederivater samt fremgangsmåder til deres fremstilling
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0604945A1 (en) 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, its derivatives, production and use thereof
EP0641776A3 (en) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Thioglycerol derivatives.
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
FR2816060A1 (fr) * 2000-10-27 2002-05-03 Pf Medicament Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules
ES2539490T3 (es) 2005-06-13 2015-07-01 Cleveland Biolabs, Inc. Métodos para proteger frente a apoptosis usando lipopéptidos
MX2008001183A (es) * 2005-07-25 2008-04-11 Therimunex Llc Peptidil diacilgliceridos.
DE102016005550A1 (de) 2016-05-09 2017-11-09 Emc Microcollections Gmbh Adjuvans zur lnduzierung einer zellulären lmmunantwort
US10907764B2 (en) * 2017-11-06 2021-02-02 Crown Equipment Corporation Industrial vehicle layover system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706490A1 (de) 1976-02-20 1977-08-25 Ciba Geigy Ag Neue carbonsaeureester

Also Published As

Publication number Publication date
PL207766A1 (pl) 1979-11-19
JPS6372671A (ja) 1988-04-02
AT364095B (de) 1981-09-25
CA1139305A (en) 1983-01-11
ATA445178A (de) 1981-02-15
FI781933A (fi) 1978-12-21
ZA783504B (en) 1979-06-27
ES478717A1 (es) 1979-12-16
AU525005B2 (en) 1982-10-14
DD139257A5 (de) 1979-12-19
PT68188A (de) 1978-07-01
JPS549224A (en) 1979-01-24
ES478718A1 (es) 1979-12-16
JPS6360760B2 (no) 1988-11-25
EP0000330B1 (de) 1981-08-05
ES470961A1 (es) 1980-03-01
DK275178A (da) 1978-12-21
JPS641466B2 (no) 1989-01-11
IE46957B1 (en) 1983-11-16
IL54950A0 (en) 1978-08-31
DE2860893D1 (en) 1981-11-05
IL54950A (en) 1983-10-31
EP0000330A1 (de) 1979-01-24
GR71681B (no) 1983-06-21
PL216740A1 (no) 1980-05-19
PL216739A1 (no) 1980-05-19
IE781227L (en) 1978-12-20
NZ187611A (en) 1981-07-13
NO148921B (no) 1983-10-03
NO782138L (no) 1978-12-21
AU3723078A (en) 1980-01-03

Similar Documents

Publication Publication Date Title
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO150314C (no) Fremgangsmaate til desodorisering av slam, spesielt klarslam
DK157487C (da) Analogifremgangsmaade til fremstilling af prolinderivater.
NO147751C (no) Fremgangsmaate til fremstilling av 4-hydroksypyrrolidin-2-on-amider.
NO148921C (no) Analogifremgangsmaate til fremstilling av immunpotenserende peptidderivater.
NO144850C (no) Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater.
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
NO156210C (no) Fremgangsmaate til fremstilling av monacolin k derivater.
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
NO152645C (no) Fremgangsmaate for fremstilling av klordioksyd.
NO781489L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
NO148924C (no) Analogifremgangsmaate ved fremstilling av immunpotensierende peptider.
NO781928L (no) Fremgangsmaate til fremstilling av guanidinderivater
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
NO152254C (no) Fremgangsmaate til fremstilling av karbazolderivater
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
NO152937C (no) Fremgangsmaate til fremstilling av et attenuert panelukopeni-virus.
NO811390L (no) Fremgangsmaate til fremstilling av 6,11-dihydro-11-oksodibenz(b,e)-oksepinalkansyrer
AR211854A1 (es) Procedimiento de preparacion de derivados polisustituidos de 10-piperazinodibenzo(b,f)tiepina
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
NO144067C (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril.
DK75778A (da) Fremgangsmaade til fremstilling af 17alfaacetylenderivater af androst-4-en.